<PAGE>
=====================================
UNITED STATES OMB Number: 3235-0058
SECURITIES AND EXCHANGE COMMISSION Expires: May 31, 1997
Washington, D.C. 20549 Estimated average burden
hours per response.............. 2.50
FORM 12B-25 SEC File Number: 1-10986
NOTIFICATION OF LATE FILING Cusip Number: 604871 103
=====================================
(check one) Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [X]
Form N-SAR [ ]
For period ended: December 31, 1998
{ } Transitions Report on Form 10-K
{ } Transitions Report on Form 20-F
{ } Transitions Report on Form 11-K
{ } Transitions Report on Form 10-Q
{ } Transitions Report on Form N-SAR
For the Transition Period Ended:________________________
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
PART I - REGISTRATION INFORMATION
MISONIX, INC.
- --------------------------------------------------------------------------------
Full Name of Registrant
- --------------------------------------------------------------------------------
Former Name if Applicable
1938 New Highway
- --------------------------------------------------------------------------------
Address of Principal Executive Office (street and number)
Farmingdale, New York 11735
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expenses and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable
effort or expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report of transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
Due to certain changes in Company personnel including the departure of the
Chief Financial Officer, compilation and transmission of the financial
information will be slightly delayed.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Edward I. Tishelman (212) 836-4940
-----------------------------------------------------------------------
Name (Area Code) Telephone Number
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed? If answer is no, identify report(s).
[X] Yes [ ] No
(3) It is anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earning statements to be included in the
subject report or portion thereof? [X] Yes [ ] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
MISONIX, INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: February 12, 1999 By: /s/ Michael A. McManus, Jr.
--------------------------------
Michael A. McManus, Jr.,
President, Chief Executive Officer and
Chief Financial Officer
INSTRUCTIONS: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute
Federal Criminal Violations(See 18 U.S.C. 1001)
<PAGE>
Attachment to Form 12B-25
Part IV (3)
Sales and income for the three months and six months, respectively,
reflected on the report will be reduced due, in large part, to the default in
performance by the licensees of the Company's ultrasonic sculpting technology,
Medical Device Alliance, Inc. and LySonix, Incorporated.
